The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children

Critical Care Medicine

Volumn 33, Issue 9, 2005, Pages 2110-2112

  Finkel, Julia C ^a   Johnson, Yewande J ^a   Quezado, Zenaide M N ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; OPIATE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG USE; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; HEART DENERVATION; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HUMAN; INFANT; INTENSIVE CARE; LUNG ATRESIA; MALE; PEDIATRIC SURGERY; PRIORITY JOURNAL; SCHOOL CHILD; SEDATION;

EID: 24944552207     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000178183.21883.23     Document Type: Article

References (16)

1. McDonald T, Hoffman WE, Berkowitz R, et al: Heart rate variability and plasma catecholamines in patients during opioid detoxification. J Neurosurg Anesthesiol 1999; 11:195-199
2. Khan ZP, Ferguson CN, Jones RM: Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54:146-165
3. Maccioli GA: Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003; 98:575-577
4. Finkel JC, Elrefai A: The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg 2004; 98:1658-1659
5. Multz AS: Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96:1054-1055
6. 3H]p- aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: Distribution of imidazoline binding sites in rat brain. Brain Res 1990; 514:15-21
7. El-Ayoubi R, Gutkowska J, Regunathan S, et al: Imidazoline receptors in the heart: Characterization, distribution, and regulation. J Cardiovasc Pharmacol 2002; 39:875-883
8. Mukaddam-Daher S, Gutkowska J: Imidazoline receptors in the heart: A novel target and a novel mechanism of action that involves atrial natriuretic peptides. Braz J Med Biol Res 2004; 37:1239-1245
9. Lane JC, Tennison MB, Lawless ST, et al: Movement disorder after withdrawal of fentanyl infusion. J Pediatr 1991; 119:649-651
10. Malviya S, Voepel-Lewis T, Tait AR, et al: Depth of sedation in children undergoing computed tomography: Validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth 2002; 88:241-245
11. Davies MF, Haimor F, Lighthall G, et al: Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg 2003; 96:195-200
12. Liem LB, DiBiase A, Schroeder JS: Arrhythmias and clinical electrophysiology of the transplanted human heart. Semin Thorac Cardiovasc Surg 1990; 2:271-278
13. Regitz V, Bossaller C, Strasser R, et al: Myocardial catecholamine content after heart transplantation. Circulation 1990; 82:620-623
14. Flacke WE, Flacke JW, Blow KD, et al: Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart. J Cardiothorac Vase Anesth 1992; 6:418-423
15. Flacke JW, Flacke WE, Bloor BC, et al: Hemodynamic effects of dexmedetomidine, an alpha 2-adrenergic agonist, in autonomically denervated dogs. J Cardiovasc Pharmacol 1990; 16:616-623
16. O'Connor PG, Kosten TR: Rapid and ultra-rapid opioid detoxification techniques. JAMA 1998; 279:229-234